- Home
- NSTS vs SER Comparison
NSTS vs SER Comparison
Compare NSTS & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSTS
- SER
- Stock Information
- Founded
- NSTS 1921
- SER 2017
- Country
- NSTS United States
- SER United States
- Employees
- NSTS N/A
- SER N/A
- Industry
- NSTS Savings Institutions
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- NSTS Finance
- SER Health Care
- Exchange
- NSTS Nasdaq
- SER Nasdaq
- Market Cap
- NSTS 63.0M
- SER 53.1M
- IPO Year
- NSTS N/A
- SER 2018
- Fundamental
- Price
- NSTS $11.54
- SER $5.03
- Analyst Decision
- NSTS
- SER Strong Buy
- Analyst Count
- NSTS 0
- SER 2
- Target Price
- NSTS N/A
- SER $13.00
- AVG Volume (30 Days)
- NSTS 1.6K
- SER 337.9K
- Earning Date
- NSTS 11-12-2025
- SER 11-11-2025
- Dividend Yield
- NSTS N/A
- SER N/A
- EPS Growth
- NSTS N/A
- SER N/A
- EPS
- NSTS N/A
- SER N/A
- Revenue
- NSTS $9,435,000.00
- SER $130,000.00
- Revenue This Year
- NSTS N/A
- SER N/A
- Revenue Next Year
- NSTS N/A
- SER N/A
- P/E Ratio
- NSTS N/A
- SER N/A
- Revenue Growth
- NSTS 69.39
- SER N/A
- 52 Week Low
- NSTS $9.50
- SER $3.81
- 52 Week High
- NSTS $13.32
- SER $10.28
- Technical
- Relative Strength Index (RSI)
- NSTS 31.07
- SER 50.48
- Support Level
- NSTS $11.80
- SER N/A
- Resistance Level
- NSTS $12.00
- SER $5.25
- Average True Range (ATR)
- NSTS 0.09
- SER 0.29
- MACD
- NSTS -0.02
- SER -0.20
- Stochastic Oscillator
- NSTS 11.68
- SER 91.53
About NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in market area of Lake County, Illinois and adjacent communities.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.